Valsartan Recalled Because of Cancer Concerns
On July 13, 2018, the FDA issued a recall of Valsartan, a drug prescribed to treat high blood pressure, after it was found to contain a carcinogen called N-nitrosodimethylamine (NDMA). Valsartan has been approved as a treatment for high blood pressure in adults and children age six and up. It is also approved for adults…